Table of Content

1 Phenprocoumon Market Overview
1.1 Product Overview and Scope of Phenprocoumon
1.2 Phenprocoumon Segment by Type
1.2.1 Global Phenprocoumon Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 5 mg
1.2.3 10 mg
1.2.4 25 mg
1.2.5 50 mg
1.3 Phenprocoumon Segment by Application
1.3.1 Phenprocoumon Sales Comparison by Application: (2021-2027)
1.3.2 Venous Thrombosis
1.3.3 Thromboembolism
1.3.4 Pulmonary Embolism
1.3.5 Others
1.4 Global Phenprocoumon Market Size Estimates and Forecasts
1.4.1 Global Phenprocoumon Revenue 2016-2027
1.4.2 Global Phenprocoumon Sales 2016-2027
1.4.3 Phenprocoumon Market Size by Region: 2016 Versus 2021 Versus 2027

2 Phenprocoumon Market Competition by Manufacturers
2.1 Global Phenprocoumon Sales Market Share by Manufacturers (2016-2021)
2.2 Global Phenprocoumon Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Phenprocoumon Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Phenprocoumon Manufacturing Sites, Area Served, Product Type
2.5 Phenprocoumon Market Competitive Situation and Trends
2.5.1 Phenprocoumon Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Phenprocoumon Players Market Share by Revenue
2.5.3 Global Phenprocoumon Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Phenprocoumon Retrospective Market Scenario by Region
3.1 Global Phenprocoumon Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Phenprocoumon Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Phenprocoumon Market Facts & Figures by Country
3.3.1 North America Phenprocoumon Sales by Country
3.3.2 North America Phenprocoumon Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Phenprocoumon Market Facts & Figures by Country
3.4.1 Europe Phenprocoumon Sales by Country
3.4.2 Europe Phenprocoumon Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Phenprocoumon Market Facts & Figures by Region
3.5.1 Asia Pacific Phenprocoumon Sales by Region
3.5.2 Asia Pacific Phenprocoumon Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Phenprocoumon Market Facts & Figures by Country
3.6.1 Latin America Phenprocoumon Sales by Country
3.6.2 Latin America Phenprocoumon Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Phenprocoumon Market Facts & Figures by Country
3.7.1 Middle East and Africa Phenprocoumon Sales by Country
3.7.2 Middle East and Africa Phenprocoumon Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Phenprocoumon Historic Market Analysis by Type
4.1 Global Phenprocoumon Sales Market Share by Type (2016-2021)
4.2 Global Phenprocoumon Revenue Market Share by Type (2016-2021)
4.3 Global Phenprocoumon Price by Type (2016-2021)

5 Global Phenprocoumon Historic Market Analysis by Application
5.1 Global Phenprocoumon Sales Market Share by Application (2016-2021)
5.2 Global Phenprocoumon Revenue Market Share by Application (2016-2021)
5.3 Global Phenprocoumon Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Phenprocoumon Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Novartis Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Phenprocoumon Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Mylan Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Phenprocoumon Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Teva Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Phenprocoumon Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Roche Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Aspen Pharmacare
6.5.1 Aspen Pharmacare Corporation Information
6.5.2 Aspen Pharmacare Description and Business Overview
6.5.3 Aspen Pharmacare Phenprocoumon Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Aspen Pharmacare Product Portfolio
6.5.5 Aspen Pharmacare Recent Developments/Updates
6.6 Acis Arzneimittel
6.6.1 Acis Arzneimittel Corporation Information
6.6.2 Acis Arzneimittel Description and Business Overview
6.6.3 Acis Arzneimittel Phenprocoumon Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Acis Arzneimittel Product Portfolio
6.6.5 Acis Arzneimittel Recent Developments/Updates
6.7 Wörwag Pharma
6.6.1 Wörwag Pharma Corporation Information
6.6.2 Wörwag Pharma Description and Business Overview
6.6.3 Wörwag Pharma Phenprocoumon Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Wörwag Pharma Product Portfolio
6.7.5 Wörwag Pharma Recent Developments/Updates
6.8 Divis Labs
6.8.1 Divis Labs Corporation Information
6.8.2 Divis Labs Description and Business Overview
6.8.3 Divis Labs Phenprocoumon Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Divis Labs Product Portfolio
6.8.5 Divis Labs Recent Developments/Updates

7 Phenprocoumon Manufacturing Cost Analysis
7.1 Phenprocoumon Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Phenprocoumon
7.4 Phenprocoumon Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Phenprocoumon Distributors List
8.3 Phenprocoumon Customers

9 Phenprocoumon Market Dynamics
9.1 Phenprocoumon Industry Trends
9.2 Phenprocoumon Growth Drivers
9.3 Phenprocoumon Market Challenges
9.4 Phenprocoumon Market Restraints

10 Global Market Forecast
10.1 Phenprocoumon Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Phenprocoumon by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Phenprocoumon by Type (2022-2027)
10.2 Phenprocoumon Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Phenprocoumon by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Phenprocoumon by Application (2022-2027)
10.3 Phenprocoumon Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Phenprocoumon by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Phenprocoumon by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Phenprocoumon Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Phenprocoumon Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Phenprocoumon Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Phenprocoumon Covered in This Study
Table 5. Global Phenprocoumon Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Phenprocoumon Sales Share by Manufacturers (2016-2021)
Table 7. Global Phenprocoumon Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Phenprocoumon Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Phenprocoumon Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Phenprocoumon Manufacturing Sites and Area Served
Table 11. Manufacturers Phenprocoumon Product Type
Table 12. Global Phenprocoumon Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Phenprocoumon by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Phenprocoumon as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Phenprocoumon Sales by Region (2016-2021) & (K Units)
Table 16. Global Phenprocoumon Sales Market Share by Region (2016-2021)
Table 17. Global Phenprocoumon Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Phenprocoumon Sales by Country (2016-2021) & (K Units)
Table 19. North America Phenprocoumon Sales Market Share by Country (2016-2021)
Table 20. North America Phenprocoumon Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Phenprocoumon Revenue Market Share by Country (2016-2021)
Table 22. Europe Phenprocoumon Sales by Country (2016-2021) & (K Units)
Table 23. Europe Phenprocoumon Sales Market Share by Country (2016-2021)
Table 24. Europe Phenprocoumon Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Phenprocoumon Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Phenprocoumon Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Phenprocoumon Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Phenprocoumon Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Phenprocoumon Revenue Market Share by Region (2016-2021)
Table 30. Latin America Phenprocoumon Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Phenprocoumon Sales Market Share by Country (2016-2021)
Table 32. Latin America Phenprocoumon Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Phenprocoumon Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Phenprocoumon Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Phenprocoumon Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Phenprocoumon Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Phenprocoumon Revenue Market Share by Country (2016-2021)
Table 38. Global Phenprocoumon Sales (K Units) by Type (2016-2021)
Table 39. Global Phenprocoumon Sales Market Share by Type (2016-2021)
Table 40. Global Phenprocoumon Revenue (Million US$) by Type (2016-2021)
Table 41. Global Phenprocoumon Revenue Share by Type (2016-2021)
Table 42. Global Phenprocoumon Price (US$/Unit) by Type (2016-2021)
Table 43. Global Phenprocoumon Sales (K Units) by Application (2016-2021)
Table 44. Global Phenprocoumon Sales Market Share by Application (2016-2021)
Table 45. Global Phenprocoumon Revenue (Million US$) by Application (2016-2021)
Table 46. Global Phenprocoumon Revenue Share by Application (2016-2021)
Table 47. Global Phenprocoumon Price (US$/Unit) by Application (2016-2021)
Table 48. Novartis Corporation Information
Table 49. Novartis Description and Business Overview
Table 50. Novartis Phenprocoumon Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Novartis Phenprocoumon Product
Table 52. Novartis Recent Developments/Updates
Table 53. Mylan Corporation Information
Table 54. Mylan Description and Business Overview
Table 55. Mylan Phenprocoumon Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Mylan Phenprocoumon Product
Table 57. Mylan Recent Developments/Updates
Table 58. Teva Corporation Information
Table 59. Teva Description and Business Overview
Table 60. Teva Phenprocoumon Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Teva Phenprocoumon Product
Table 62. Teva Recent Developments/Updates
Table 63. Roche Corporation Information
Table 64. Roche Description and Business Overview
Table 65. Roche Phenprocoumon Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Roche Phenprocoumon Product
Table 67. Roche Recent Developments/Updates
Table 68. Aspen Pharmacare Corporation Information
Table 69. Aspen Pharmacare Description and Business Overview
Table 70. Aspen Pharmacare Phenprocoumon Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Aspen Pharmacare Phenprocoumon Product
Table 72. Aspen Pharmacare Recent Developments/Updates
Table 73. Acis Arzneimittel Corporation Information
Table 74. Acis Arzneimittel Description and Business Overview
Table 75. Acis Arzneimittel Phenprocoumon Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Acis Arzneimittel Phenprocoumon Product
Table 77. Acis Arzneimittel Recent Developments/Updates
Table 78. Wörwag Pharma Corporation Information
Table 79. Wörwag Pharma Description and Business Overview
Table 80. Wörwag Pharma Phenprocoumon Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Wörwag Pharma Phenprocoumon Product
Table 82. Wörwag Pharma Recent Developments/Updates
Table 83. Divis Labs Corporation Information
Table 84. Divis Labs Description and Business Overview
Table 85. Divis Labs Phenprocoumon Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Divis Labs Phenprocoumon Product
Table 87. Divis Labs Recent Developments/Updates
Table 88. Production Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Phenprocoumon Distributors List
Table 91. Phenprocoumon Customers List
Table 92. Phenprocoumon Market Trends
Table 93. Phenprocoumon Growth Drivers
Table 94. Phenprocoumon Market Restraints
Table 95. Global Phenprocoumon Sales Forecast by Type (2022-2027) & (K Units)
Table 96. Global Phenprocoumon Sales Market Share Forecast by Type (2022-2027)
Table 97. Global Phenprocoumon Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 98. Global Phenprocoumon Revenue Market Share Forecast by Type (2022-2027)
Table 99. Global Phenprocoumon Sales Forecast by Application (2022-2027) & (K Units)
Table 100. Global Phenprocoumon Sales Market Share Forecast by Application (2022-2027)
Table 101. Global Phenprocoumon Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 102. Global Phenprocoumon Revenue Market Share Forecast by Application (2022-2027)
Table 103. Global Phenprocoumon Sales Forecast by Region (2022-2027) & (K Units)
Table 104. Global Phenprocoumon Sales Market Share Forecast by Region (2022-2027)
Table 105. Global Phenprocoumon Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 106. Global Phenprocoumon Revenue Market Share Forecast by Region (2022-2027)
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Phenprocoumon
Figure 2. Global Phenprocoumon Market Share by Type in 2020 & 2027
Figure 3. 5 mg Product Picture
Figure 4. 10 mg Product Picture
Figure 5. 25 mg Product Picture
Figure 6. 50 mg Product Picture
Figure 7. Global Phenprocoumon Market Share by Application in 2020 & 2027
Figure 8. Venous Thrombosis
Figure 9. Thromboembolism
Figure 10. Pulmonary Embolism
Figure 11. Others
Figure 12. Global Phenprocoumon Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Phenprocoumon Market Size 2016-2027 (US$ Million)
Figure 14. Global Phenprocoumon Sales 2016-2027 (K Units)
Figure 15. Global Phenprocoumon Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Phenprocoumon Sales Share by Manufacturers in 2020
Figure 17. Global Phenprocoumon Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Phenprocoumon Players: Market Share by Revenue in 2020
Figure 19. Phenprocoumon Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Phenprocoumon Sales Market Share by Region (2016-2021)
Figure 21. Global Phenprocoumon Sales Market Share by Region in 2020
Figure 22. Global Phenprocoumon Revenue Market Share by Region (2016-2021)
Figure 23. Global Phenprocoumon Revenue Market Share by Region in 2020
Figure 24. U.S. Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE Phenprocoumon Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Phenprocoumon by Type (2016-2021)
Figure 49. Sales Market Share of Phenprocoumon by Application (2016-2021)
Figure 50. Sales Market Share of Phenprocoumon by Application in 2020
Figure 51. Revenue Share of Phenprocoumon by Application (2016-2021)
Figure 52. Revenue Share of Phenprocoumon by Application in 2020
Figure 53. Manufacturing Cost Structure of Phenprocoumon
Figure 54. Manufacturing Process Analysis of Phenprocoumon
Figure 55. Phenprocoumon Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed